Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs11803919 | chr1:227228955 | G/A | 2.43E-5 | 176 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11804181 | chr1:227443937 | A/C | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11804271 | chr1:227563700 | T/A | 6.96E-5 | 176 | 15.4 | 16.45 | 3.9 | KM Plot |
| PAAD | rs11804807 | chr1:227354001 | C/A | 3.51E-5 | 177 | 15.57 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11805012 | chr1:227221683 | G/A | 4.08E-5 | 176 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11805662 | chr1:227238540 | G/A | 3.2E-5 | 178 | 15.53 | 15.65 | 3.9 | KM Plot |
| PAAD | rs11806633 | chr1:227308416 | C/T | 3.2E-5 | 178 | 3.9 | 15.65 | 15.53 | KM Plot |
| PAAD | rs11806721 | chr1:227514987 | A/T | 4.72E-5 | 178 | 3.9 | 15.65 | 15.53 | KM Plot |
| PAAD | rs11807068 | chr1:227514908 | T/G | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11807375 | chr1:227511411 | A/G | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11807425 | chr1:227511793 | A/C | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11807957 | chr1:227509751 | G/A | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11808210 | chr1:227515049 | G/A | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11808670 | chr1:227516011 | G/A | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11808674 | chr1:227516077 | G/T | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |